Alzheimer Disease

Roche Receives FDA Clearance for Elecsys pTau181 — the First Blood-Based Test to Aid in the Early Assessment of Alzheimer’s Disease

Roche Receives FDA Clearance for Elecsys pTau181 — the First Blood-Based Test to Aid in the Early Assessment of Alzheimer’s Disease

14 Oct 2025

2 min read

ReCODE Protocol Shows Promise in Reducing Depression Among Patients with Cognitive Impairment

Precision Medicine

ReCODE Protocol Shows Promise in Reducing Depression Among Patients with Cognitive Impairment

27 Sep 2025

2 min read

European Commission Grants Marketing Authorization for Eli Lilly’s Kisunla in Early Symptomatic Alzheimer’s Disease

European Commission Grants Marketing Authorization for Eli Lilly’s Kisunla in Early Symptomatic Alzheimer’s Disease

26 Sep 2025

2 min read

Read More

Voice Of HealthCare

vohnetwork.com